Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.

Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrosp...

Full description

Bibliographic Details
Main Authors: Lohman, B, Slyker, J, Richardson, B, Farquhar, C, Mabuka, J, Crudder, C, Dong, T, Obimbo, E, Mbori-Ngacha, D, Overbaugh, J, Rowland-Jones, S, John-Stewart, G
Format: Journal article
Language:English
Published: 2005
_version_ 1826302586136821760
author Lohman, B
Slyker, J
Richardson, B
Farquhar, C
Mabuka, J
Crudder, C
Dong, T
Obimbo, E
Mbori-Ngacha, D
Overbaugh, J
Rowland-Jones, S
John-Stewart, G
author_facet Lohman, B
Slyker, J
Richardson, B
Farquhar, C
Mabuka, J
Crudder, C
Dong, T
Obimbo, E
Mbori-Ngacha, D
Overbaugh, J
Rowland-Jones, S
John-Stewart, G
author_sort Lohman, B
collection OXFORD
description Human immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-gamma) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (P = 0.09), and in approximately 50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10(6) peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10(6) PBMC at 12 months of age (P = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (P = 0.18). Over the first year of life, infants with IFN-gamma responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-gamma responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8+-T-cell responses early in life that are not clearly associated with improved clinical outcomes.
first_indexed 2024-03-07T05:49:50Z
format Journal article
id oxford-uuid:e87c75f7-9451-463f-802c-37ac8887ee5d
institution University of Oxford
language English
last_indexed 2024-03-07T05:49:50Z
publishDate 2005
record_format dspace
spelling oxford-uuid:e87c75f7-9451-463f-802c-37ac8887ee5d2022-03-27T10:47:09ZLongitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e87c75f7-9451-463f-802c-37ac8887ee5dEnglishSymplectic Elements at Oxford2005Lohman, BSlyker, JRichardson, BFarquhar, CMabuka, JCrudder, CDong, TObimbo, EMbori-Ngacha, DOverbaugh, JRowland-Jones, SJohn-Stewart, GHuman immunodeficiency virus type 1 (HIV-1) infection results in different patterns of viral replication in pediatric compared to adult populations. The role of early HIV-1-specific responses in viral control has not been well defined, because most studies of HIV-1-infected infants have been retrospective or cross-sectional. We evaluated the association between HIV-1-specific gamma interferon (IFN-gamma) release from the cells of infants of 1 to 3 months of age and peak viral loads and mortality in the first year of life among 61 Kenyan HIV-1-infected infants. At 1 month, responses were detected in 7/12 (58%) and 6/21 (29%) of infants infected in utero and peripartum, respectively (P = 0.09), and in approximately 50% of infants thereafter. Peaks of HIV-specific spot-forming units (SFU) increased significantly with age in all infants, from 251/10(6) peripheral blood mononuclear cells (PBMC) at 1 month of age to 501/10(6) PBMC at 12 months of age (P = 0.03), although when limited to infants who survived to 1 year, the increase in peak HIV-specific SFU was no longer significant (P = 0.18). Over the first year of life, infants with IFN-gamma responses at 1 month had peak plasma viral loads, rates of decline of viral load, and mortality risk similar to those of infants who lacked responses at 1 month. The strength and breadth of IFN-gamma responses at 1 month were not significantly associated with viral containment or mortality. These results suggest that, in contrast to HIV-1-infected adults, in whom strong cytotoxic T lymphocyte responses in primary infection are associated with reductions in viremia, HIV-1-infected neonates generate HIV-1-specific CD8+-T-cell responses early in life that are not clearly associated with improved clinical outcomes.
spellingShingle Lohman, B
Slyker, J
Richardson, B
Farquhar, C
Mabuka, J
Crudder, C
Dong, T
Obimbo, E
Mbori-Ngacha, D
Overbaugh, J
Rowland-Jones, S
John-Stewart, G
Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title_full Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title_fullStr Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title_full_unstemmed Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title_short Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.
title_sort longitudinal assessment of human immunodeficiency virus type 1 hiv 1 specific gamma interferon responses during the first year of life in hiv 1 infected infants
work_keys_str_mv AT lohmanb longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT slykerj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT richardsonb longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT farquharc longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT mabukaj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT crudderc longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT dongt longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT obimboe longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT mboringachad longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT overbaughj longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT rowlandjoness longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants
AT johnstewartg longitudinalassessmentofhumanimmunodeficiencyvirustype1hiv1specificgammainterferonresponsesduringthefirstyearoflifeinhiv1infectedinfants